Nami Surgical

Nami Surgical

Private
Glasgow, ScotlandHealthcare & Life Scienceshttps://namisurgical.com

Last Round

Series A

Aug 15, 2025

Total Funding Raised

$3.1M

Company Overview

Nami Surgical is a medical technology company that develops ultrasonic surgical tools aimed at revolutionizing robotic-assisted surgery with innovative technology that simplifies procedures and enhances clinical outcomes.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Industrial Robotics

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting, Government Contracts

AI Layer

Non-AI

Keywords

ultrasonic scalpelrobotic-assisted surgeryRASrobotic surgerysurgical roboticsultrasonic surgical instrumentsmedtechminiaturized surgical toolslaparoscopic surgeryultrasonic generatorsmedical deviceurology surgerygynecology surgerycolorectal surgery

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Nami Surgical Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Nami Surgical Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series AAug 15, 2025
SeedMay 8, 2024

Key People

Founding team and executive leadership

Rebecca Shirley Cleary

Co-Founder And CTO

Founding Team

Nico Fenu

Chief Executive Officer, Founder And Director

Founding Team

Nami Surgical Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 29, 2026

    Nikki Palfrey named new Chief Executive Officer.

  • Mar 6, 2025

    David O'Reilly joins as corporate strategy advisor.

Nami Surgical Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Nami Surgical Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Nami Surgical's valuation, stock price, and market status.

Firmographic Details

HeadquartersGlasgow, Scotland
Employee Range19
Year Founded2014
Last FundingAug 15, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.